Meet Proteona at BIO-Europe Digital 2020
Innovative AI-driven genomic and proteomic analysis platform for improving cell therapy and immuno-oncology
Proteona will attend the BIO-Europe Digital Conference 2020, taking place on 26-29 October 2020. Catch up with us during the event to discuss the recent development in single cell multi-omics and oncology precision medicine!
Proteona is currently performing multiple clinical projects in Europe and Asia with a key focus on Multiple Myeloma. Proteona is also providing single cell proteogenomics analysis and bioinformatics services for biotech and pharma partners around the world.
BIO-Europe is the largest biotech and life sciences partnering event in Europe. This year, the one-to-one partnering is taking place online.
Book an appointment with Proteona through the event partneringONE® platform now!
For media queries, please contact:
Dr Andreas Schmidt
Proteona is a precision medicine company in Singapore, Germany, and the US that is pioneering the use of single cell multi-omics to improve clinical outcomes in cancer. Using a combination of innovative single cell assays and AI-assisted bioinformatics, Proteona enables pharmaceutical companies, biotech partners, and clinicians to integrate single cell level precision into their clinical projects. Proteona continues to develop comprehensive, disease-specific single cell databases combining gene expression, protein expression, and mutation information derived from each individual cells as well as drug response data for each sample. Proteona has been selected as a “One to Watch” by Nature Research Spinoff Award and a Winner of Falling Walls Ventures Breakthrough of the Year 2020. Proteona is a spin-off from the National University of Singapore (NUS) and the Agency for Science, Technology and Research (A*STAR).